The Obama administration looks to be a welcome shot in the arm for the scientific endeavor, but the current economic crisis is likely to keep several issues of key interest to biotech firmly on the back burner.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. Biotech under Barack. Nat Biotechnol 27, 237–244 (2009). https://doi.org/10.1038/nbt0309-237
Issue Date:
DOI: https://doi.org/10.1038/nbt0309-237
This article is cited by
-
Healthcare reform looms, firms seek scraps from US stimulus
Nature Biotechnology (2009)